Management of Gastrointestinal Bleeding

  • Paul Ellis Marik

Abstract

  • The urgency with which gastrointestinal (GI) bleeding is managed is dictated by the rate of bleeding.
    • The patient with trace heme-positive stools and without severe anemia can be managed as an outpatient.

    • Visible blood requires hospitalization and inpatient evaluation.

    • Persistent bleeding or rebleeding with hemodynamic instability necessitates ICU admission.

    • Massive bleeding is defined as loss of ≥30% of estimated blood volume or bleeding requiring blood transfusion of ≥6 U/24 hours.

  • Hemodynamic assessment: blood pressure, pulse, postural changes and assessment of peripheral perfusion.

  • The presence of comorbid disease must be determined.

  • Estimating blood loss. This can be estimated by measuring the return from a nasogastric (NG) tube. An approximate estimate of blood loss can be made by the hemodynamic response to a 2- L crystalloid fluid challenge:
    • If blood pressure (BP) returns to normal and stabilizes, blood loss of 15% to 30% has occurred.

    • If BP rises but falls again, blood volume loss of 30% to 40% has occurred.

    • If BP continues to fall, blood volume loss of >40% has probably occurred.

  • History and examination: Attempt to localize most likely source of bleeding.
    • The presence of melena indicates upper GI bleeding.

    • Hematemesis indicates upper GI bleeding.

    • When small amounts of bright red blood are passed per rectum, the lower GI tract can be assumed to be the source.

    • In patients with large-volume maroon stools, NG tube aspiration should be performed to exclude upper GI hemorrhage. It should be noted that in about 15% of patients with upper GI bleeding, NG aspirate will fail to obtain blood or “coffeeground” material. In most cases, concerns that placement of an NG tube may induce bleeding in patients with coagulopathies are outweighed by the benefits of the information obtained.

  • An NG tube should be inserted in all patients with upper GI bleeding to decompress the stomach. No data suggest that NG tube placement may initiate or potentiate bleeding in patients with esophageal varices. NG tube placement is essential to monitor ongoing bleeding and to decompress the stomach.

Keywords

Placebo Anemia Radionuclide Stratification Adrenaline 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected References

  1. 1.
    Barange K, Peron JM, Imani K, et al.Transjugular intrahepatic porosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology. 1999;30:1139–1143.PubMedCrossRefGoogle Scholar
  2. 2.
    Bernard B, Grange JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655–1661.PubMedCrossRefGoogle Scholar
  3. 3.
    Chung SS, Lau JY, Sung JJ, et al. Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. BMJ. 1997;314:1307–1311.PubMedCrossRefGoogle Scholar
  4. 4.
    Corley DA, Stefan AM, Wolf M, Cook EF, Lee TH. Early indicators of prognosis in upper gastrointestinal hemorrhage. Am J Gastroenterol. 1998; 93:336–340.PubMedCrossRefGoogle Scholar
  5. 5.
    Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med. 1997;336:1054–1058.PubMedCrossRefGoogle Scholar
  6. 6.
    Kollef MH, Canfield DA, Zuckerman GR. Triage considerations for patients with acute gastrointestinal hemorrhage admitted to a medical intensive care unit. Crit Care Med. 1995;23:1048–1054.PubMedCrossRefGoogle Scholar
  7. 7.
    Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med. 1998;158:54–58.PubMedCrossRefGoogle Scholar
  8. 8.
    Peterson WL, Cook DJ. Antisecretory therapy for bleeding peptic ulcer. JAMA. 1998;280:877–878.PubMedCrossRefGoogle Scholar
  9. 9.
    Rockall TA, Logan RF, Devlin HB, Northfield TC. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet. 1996;347:1138–1140.PubMedCrossRefGoogle Scholar
  10. 10.
    Sanyal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology. 1996;111:138–146.PubMedCrossRefGoogle Scholar
  11. 11.
    Sung JJ, Chung SC, Yung MY, et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet. 1995;346:1666–1669.PubMedCrossRefGoogle Scholar
  12. 12.
    Tait IS, Krige JE, Terblanche J. Endoscopic band ligation of oesophageal varices. Br J Surg. 1999;86:437–446.PubMedCrossRefGoogle Scholar
  13. 13.
    Villanueva C, Balanzo J, Novella MT, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med. 1996;334:1624–1629.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 2001

Authors and Affiliations

  • Paul Ellis Marik
    • 1
  1. 1.Critical Care MedicineMercy Hospital of PittsburghPittsburghUSA

Personalised recommendations